Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

Keytruda Retains Top Selling Status Amid Rising Popularity of GLP-1 Medications - BioSpace

04 Mar, 2026

Johnson & Johnson and AbbVie: A Competitive Growth Battle in the Face of Patent Expirations

23 Feb, 2026

Will Immunology Medications Keep Boosting AbbVie's Revenue in 2026? - TradingView

20 Feb, 2026

Analysis of the Patent Landscape for Cancer and Antibody Conjugates - GlobeNewswire

19 Feb, 2026

See More